Serum-soluble interleukin-2 receptor (sIL-2R) is an extremely strong prognostic factor for patients with peripheral T-cell lymphoma, unspecified (PTCL-U)

✍ Scribed by Jun-ichi Kitagawa; Takeshi Hara; Hisashi Tsurumi; Naoe Goto; Nobuhiro Kanemura; Takeshi Yoshikawa; Senji Kasahara; Toshiki Yamada; Michio Sawada; Takeshi Takahashi; Masahito Shimizu; Tsuyoshi Takami; Hisataka Moriwaki

• Publisher: Springer-Verlag
• Year: 2008
• Tongue: English
• Weight: 330 KB
• Volume: 135
• Category: Article
• ISSN: 1432-1335
• DOI: 10.1007/s00432-008-0440-0